INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 127 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,504 | -92.7% | 268,650 | -91.6% | 0.00% | – |
| Q2 2023 | $1,427,050 | +86.3% | 3,196,081 | +242.1% | 0.00% | – |
| Q1 2023 | $765,978 | +58.6% | 934,120 | +201.7% | 0.00% | – |
| Q4 2022 | $482,978 | +600.0% | 309,601 | +676.3% | 0.00% | – |
| Q3 2022 | $69,000 | -72.0% | 39,881 | -72.0% | 0.00% | – |
| Q2 2022 | $246,000 | -87.3% | 142,436 | -73.5% | 0.00% | – |
| Q1 2022 | $1,930,000 | -47.9% | 537,503 | -27.5% | 0.00% | -100.0% |
| Q4 2021 | $3,701,000 | -29.7% | 741,743 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $5,266,000 | -28.8% | 735,600 | -7.8% | 0.00% | -66.7% |
| Q2 2021 | $7,395,000 | -44.3% | 797,731 | -44.2% | 0.00% | -50.0% |
| Q1 2021 | $13,265,000 | -13.8% | 1,429,439 | -17.8% | 0.01% | -25.0% |
| Q4 2020 | $15,387,000 | -67.6% | 1,738,682 | -57.5% | 0.01% | -72.4% |
| Q3 2020 | $47,454,000 | -71.3% | 4,090,927 | -33.3% | 0.03% | -76.8% |
| Q2 2020 | $165,340,000 | +1388.6% | 6,135,038 | +311.0% | 0.12% | +1036.4% |
| Q1 2020 | $11,107,000 | +18108.2% | 1,492,877 | +4911.2% | 0.01% | – |
| Q3 2019 | $61,000 | -77.8% | 29,791 | -68.2% | 0.00% | – |
| Q2 2019 | $275,000 | +316.7% | 93,656 | +692.9% | 0.00% | – |
| Q3 2018 | $66,000 | -10.8% | 11,812 | -24.9% | 0.00% | – |
| Q1 2018 | $74,000 | +21.3% | 15,722 | +6.6% | 0.00% | – |
| Q4 2017 | $61,000 | -7.6% | 14,750 | +41.8% | 0.00% | – |
| Q3 2017 | $66,000 | -38.9% | 10,400 | -24.6% | 0.00% | – |
| Q2 2017 | $108,000 | -61.4% | 13,800 | -54.4% | 0.00% | -100.0% |
| Q2 2016 | $280,000 | +105.9% | 30,254 | +93.3% | 0.00% | +100.0% |
| Q1 2016 | $136,000 | +2.3% | 15,653 | -31.9% | 0.00% | 0.0% |
| Q3 2015 | $133,000 | -23.1% | 22,983 | +8.6% | 0.00% | 0.0% |
| Q2 2015 | $173,000 | -79.5% | 21,169 | -72.8% | 0.00% | -90.9% |
| Q2 2014 | $843,000 | – | 77,953 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |